I. Life Science: Science Meets Strategy

We focus on clinical-stage biotechnology and MedTech innovations. By leveraging our network of former Pharma CEOs and clinical experts, we look beyond the balance sheet to evaluate the underlying science and back the breakthroughs of tomorrow.

II. German Real Estate: Stability in Europe’s Engine

We specialize in identifying undervalued residential and commercial assets in Germany’s key economic hubs. Our advantage lies in our deep local roots and ability to navigate complex zoning and regulatory landscapes.

III. Disruptive Technologies: Backing the Builders

We invest in disruptive tech companies redefining B2B software, AI, and Green-tech. This pillar is driven by our network of serial entrepreneurs who identify winners by analyzing product-market fit through the lens of those who have built it themselves.